摘要
目的:研究黑顺片与大黄联用对次乌头碱在大鼠体内药动学的影响。方法:取大鼠随机分为单用(黑顺片单煎液)组和联用(黑顺片-大黄合煎液)组,每组18只,ig相应药物,给药剂量均按黑顺片计为10 g(生药)/kg。分别于给药前(0 h)和给药后0.083、0.167、0.333、0.5、0.75、1、1.5、2、3、4、6、8、10 h采血0.3 ml,每个时间点取6只,采用高效液相色谱-质谱法,以盐酸巴马汀为内标,测定次乌头碱的血药浓度。利用DAS2.0.1药动学软件计算药动学参数。结果:次乌头碱检测质量浓度的线性范围为0.1024~100 ng/ml(r=0.9987),定量限为0.1 ng/ml。其在单用组和联用组大鼠体内的药动学参数tmax分别为(0.50±0.086)、(0.75±0.132)h,t1/2分别为(9.967±1.123)、(3.708±0.507)h,AUC0-10 h分别为(26.087±0.672)、(6.516±1.135)μg·h/L,cmax分别为(6.124±2.312)、(1.592±0.051)μg/L;与单用组比较,联用组大鼠体内次乌头碱的t1/2、AUC0-10 h、cmax均减小,差异有统计学意义(P<0.05)。结论:大黄可以抑制次乌头碱在大鼠体内的吸收,加快其在体内的消除。
OBJECTIVE:To study the effects of Heishun tablets combined with Rheum palmatum on the pharmacokinetics of hypaconitine in rats. METHODS:Rats were randomly divided into single drug group(Heishun tablets decoction)and drug combi-nation group(Heishun tablets-R. palmatum mixture decoction),with 18 rats in each group. They were given relevant drugs intragas-trically,by 10 g(medicinal materials)/kg of Heishun tablets. 0.3 ml blood samples were collected before(0 h)and 0.083,0.167, 0.333,0.5,0.75,1,1.5,2,3,4,6,8,10 h after medication with 6 rats at each time point,respectively. The blood concentra-tion of hypaconitine was determined by HPLC-MS using palmatine hydrochloride as internal standard. DAS 2.0.1 software was used to calculate pharmacokinetic parameters. RESULTS:The linear range of hypaconitine was 0.102 4-100 ng/ml (r=0.998 7),and the limit of quantification was 0.1 ng/ml. The pharmacokinetic parameters of single drug group vs. drug combination group were as follows as tmax of (0.50 ± 0.086) h vs. (0.75 ± 0.132)h;t1/2 of (9.967 ± 1.123) h vs. (3.708 ± 0.507) h;AUC0-10 h of (26.087 ± 0.672) μg·h/L vs.(6.516 ± 1.135) μg·h/L;cmax of (6.124 ± 2.312) μg/L vs. (1.592 ± 0.051) μg/L. Compared with single drug group,t1/2,AUC0-10 h and cmax of hypaconitine were decreased in drug combination group,with statistical significance (P〈0.05). CONCLUSIONS:R. palmatum can inhibit the absorption of hypaconitine in rats,and speed up the elimination of it in rats.
出处
《中国药房》
CAS
北大核心
2015年第28期3950-3952,共3页
China Pharmacy